Tabiat

Tabiat Research Inc., operating as Tabiat, is a healthcare technology firm based in Toronto that provides a remote patient monitoring platform focused on chronic obstructive pulmonary disease (COPD). The company was co-founded by brothers Daniyal Liaqat, who serves as CEO, and Salaar Liaqat, the CTO. The venture originated from Daniyal Liaqat's PhD research at the University of Toronto, which explored using machine learning and continuous sensing from wearable devices for monitoring chronic diseases. This academic foundation, centered on a thesis titled "Towards Continuous Mobile Sensing for Remote COPD Monitoring," directly informs the company's core technology. Daniyal's background includes a PhD in Computer Science from the University of Toronto and postdoctoral work at the Vector Institute, providing him with a strong foundation in AI and healthcare applications.

Incorporated on March 9, 2020, Tabiat has secured seed funding from investors including Right Side Capital Management and UTEST. The firm targets healthcare providers, clinics, and hospitals, offering a turnkey service to manage patients with chronic lung conditions outside traditional clinical settings. The business model is structured to generate revenue for healthcare providers by utilizing CPT codes for remote patient monitoring, effectively creating a new revenue stream for services their teams are already providing. Tabiat offers a comprehensive program that includes patient onboarding, providing them with necessary monitoring devices, and daily oversight by a dedicated nursing team supported by an AI-powered platform. This approach aims to reduce the workload on clinic staff and seamlessly integrate into existing electronic medical records (EMR) and workflows.

The platform's primary function is to enable the early detection of health deteriorations, thereby preventing hospitalizations and emergency department visits. Patients use a mobile app and wearable devices to track vital signs, symptoms, and medication adherence. This data is monitored by Tabiat's nursing team, with an AI system that flags at-risk individuals for proactive intervention. The service is designed to bridge the care gap between hospital discharge and home, providing continuous monitoring and support. The platform has been validated through pilot programs involving over 350 patients and 20 doctors across major hospitals, demonstrating its real-world applicability and achieving high patient adherence rates.

Keywords: remote patient monitoring, COPD management, healthcare AI, patient monitoring platform, chronic disease management, telehealth, digital health, wearable sensing, clinical decision support, patient adherence, hospital readmission reduction, healthcare workflow integration, remote nursing support, mobile health, preventative care, AI-powered healthcare, chronic care, vital signs monitoring, medication adherence, healthcare technology